4//SEC Filing
Rawlins Dave 4
Accession 0001628280-20-016613
CIK 0001402479other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:23 PM ET
Size
8.1 KB
Accession
0001628280-20-016613
Insider Transaction Report
Form 4
Rawlins Dave
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-11-17+224,630→ 224,630 totalExercise: $1.71From: 2020-11-17Exp: 2029-12-12→ Common Stock (224,630 underlying) - Award
Stock Option (Right to Buy)
2020-11-17+74,320→ 298,950 totalExercise: $1.71From: 2020-11-17Exp: 2030-04-24→ Common Stock (74,320 underlying)
Footnotes (3)
- [F1]Price in Canadian dollars.
- [F2]1/48 of the shares vest monthly beginning on August 12, 2019, subject to the Reporting Person continuing as a service provider through each such date.
- [F3]1/48 of the shares vest monthly beginning on February 28, 2020, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
MYOS RENS TECHNOLOGY INC.
CIK 0001402479
Entity typeother
Related Parties
1- filerCIK 0001831677
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 7:23 PM ET
- Size
- 8.1 KB